WNT3A and breast carcinoma: Specifically, WNT3A was reported in many cancer studies as a major participant in malignant cell invasion, including cancer types such as hepatocellular carcinoma [78,79,80], glioma [81], breast cancer [82], esophageal cancer [83], and colon cancer [84].